Dierikon (ots) - In Wallisellen gibt es die erste Schweizer Thermomix-Showküche. Am Tag der offenen Tür ...
Quintiles Asia Pacific Receives Frost & Sullivan Awards
Research Triangle Park, North Carolina (ots/PRNewswire) -
- Multinational Clinical Trials Service Provider of the Year and Multinational CRO of the Year
Quintiles Transnational Corp. today announced that its Quintiles East Asia subsidiary has been named the Asia Pacific region's Multinational Clinical Trials Service Provider of the Year and Multinational CRO of the Year by the consulting firm Frost & Sullivan.
Frost & Sullivan presents the awards to companies that demonstrate "best practices in their industry, commending the diligence, commitment and innovative business strategies required to advance in the global marketplace."
Anand Tharmaratnam, M.D., CEO of Quintiles East Asia and Head of Asia Pacific Clinical Development, accepted the Multinational CRO of the Year award. Michael Stibilj, Executive Director of Southeast Asia Clinical Development, accepted the Multinational Clinical Trials Service Provider of the Year award.
"We owe this award to the vision of our founder, Dennis Gillings, who pioneered the CRO industry in Asia Pacific during the early and mid-1990s, and to our team of dedicated professionals who have used their expertise to create best-in-class service," Tharmaratnam said. "We also have been fortunate to work with government institutions, including the Singapore Economic Development Board, that have created a climate ideal for drug development."
Last year, Quintiles started 76 new clinical trials and has a total of more than 200 ongoing in the Asia Pacific region. The company also opened new offices in Vietnam and Indonesia, in addition to existing offices in Australia, New Zealand, China, Korea, Malaysia, Philippines, Singapore, Taiwan and Thailand. The company has about 320 regular clinical research employees in the region.
Stibilj said the area is ideal for clinical research. "It has the right mix of excellent hospital infrastructure, highly motivated investigators, a stable regulatory environment and a broad spectrum of diseases common in the developing and developed world," he said. "Our customers recognize that our people and solutions make Quintiles the leader in Asia Pacific and the world as well."
Frost & Sullivan selects the award winners using rigorous measurement-based methodologies. The awards were presented at a Frost & Sullivan Asia Pacific Healthcare Best Practice Awards banquet in Singapore.
About Quintiles Asia Pacific
Quintiles Asia Pacific has clinical development offices in 11 countries. Since 1993, the Quintiles clinical team in Asia Pacific has completed over 500 clinical trials involving about 2,500 sites and more than 60,000 patients.
Quintiles is the global leader in pharmaceutical services, improving healthcare worldwide by providing innovative, quality professional expertise, market intelligence and partnering solutions to meet the dynamic needs of the pharmaceutical, biotechnology and healthcare industries. Quintiles has 16,000 specialized employees and offices in 50 countries. For more information visit the company's Web site at www.quintiles.com.
Web site: http://www.quintiles.com
ots Originaltext: Quintiles Transnational Corp.
Im Internet recherchierbar: http://www.presseportal.ch
Dick Jones, Media Relations, +1-919-998-2091, or
firstname.lastname@example.org, or Greg Connors, Investor Relations,
+1-919-998-2000, or email@example.com, both of Quintiles